Skip to content

Study on the clinical effect and immune effect of cryoablation in the treatment of small breast cancer

Study on the clinical effect and immune effect of cryoablation in the treatment of small breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092949
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Women; ? Age = 18 years old; ? Sign the informed consent form and be able to comply with the requirements of the plan; ? The patient was diagnosed as invasive breast cancer by thick needle aspiration pathology without treatment; ? Breast ultrasound examination evaluated the tumor as cT1-2, and breast mammography and breast MRI (plain scan+enhanced) were performed simultaneously; ? Imaging examinations such as breast ultrasound, mammography, and breast MRI (plain scan+enhanced) assessed a single lesion tumor, with no other suspected malignant breast tumors; ? When the patient is in a supine position, breast ultrasound examination shows no adhesion between the tumor and the chest wall, nipple, or skin, and the tumor is at least 1cm away from the skin; ? Whole body assessment show

Exclusion criteria

Exclusion criteria: ? Multicentric or multifocal breast tumors; ? Tumors in the nipple and areola area; ? Imaging examination shows diffuse distribution of malignant characteristic calcifications or scattered intraductal cancer signs; ? Pathology showed that invasive breast cancer was accompanied by extensive intraductal carcinoma (more than 50% of the tumor volume was intraductal carcinoma); ? Inflammatory breast cancer; ? The skin in the treatment area is infiltrated by tumors or has ulceration; ? Patients who are pregnant or breastfeeding; ? Prior to enrollment, received systemic chemotherapy, targeted drug therapy, or local radiation therapy; ? KPS score2 points; ? There are foreign bodies implanted around the tumor.

Design outcomes

Primary

MeasureTime frame
complete ablation rate;

Secondary

MeasureTime frame
Incidence of adverse events;

Countries

China

Contacts

Public Contactshui wang

Breast Disease Center, the First Affiliated Hospital of Nanjing Medical University

shwang@njmu.edu.cn+86 137 0145 8115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026